Pam Murphy | Investor Relations |
Bill Collier | President & Chief Executive Officer |
Dave Hastings | Chief Financial Officer |
Gaston Picchio | Chief Development Officer |
Mike Sofia | Chief Scientific Officer |
Mayank Mamtani | B. Riley |
Roy Buchanan | JMP Securities |
Ladies and gentlemen, thank you for standing by and welcome to Arbutus Biopharma Corporation 2020 Third Quarter Financial Results and Corporate Update. At this time, all participants lines are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to hand the conference over to Pam Murphy, you may begin.